Therapie

Papers
(The H4-Index of Therapie is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Uses of pharmacovigilance databases: An overview90
“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers87
Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection70
Safety data and withdrawal of hepatotoxic drugs53
Addictovigilance contribution during COVID-19 epidemic and lockdown in France51
Pharmacovigilance and drug safety: Fair prescribing and clinical research48
Drug repositioning for rare diseases: Knowledge-based success stories41
Polypharmacy: A general review of definitions, descriptions and determinants37
Drug repurposing in rare diseases: Myths and reality35
Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence33
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)30
Efficacy of COVID-19 vaccines: From clinical trials to real life29
Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations26
Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres25
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge23
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy21
Diabetes and COVID-1921
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France20
Prolonged-release buprenorphine formulations: Perspectives for clinical practice19
Chloroquine and hydroxychloroquine during pregnancy: What do we know?19
0.024488210678101